Linden Capital Partners Acquires Alcresta Therapeutics
March 12, 2024
Chicago-based private equity firm Linden Capital Partners has completed its acquisition of Alcresta Therapeutics from a group led by Athyrium Capital, with Bessemer Venture Partners, Frazier Healthcare Partners and HealthQuest Capital also selling (HealthQuest reinvested as a minority shareholder). Linden will work with Alcresta's management and a newly assembled board to support the commercial launch of the next-generation RELiZORB device and accelerate R&D and growth.
- Buyers
- Linden Capital Partners
- Targets
- Alcresta Therapeutics, Inc.
- Sellers
- Athyrium Capital, Bessemer Venture Partners, Frazier Healthcare Partners, HealthQuest Capital
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.